nadolol and dolutegravir

nadolol has been researched along with dolutegravir in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Álvarez, M; Cheng, X; De Clercq, E; Gao, P; Liu, X; Luczkowiak, J; Menéndez-Arias, L; Pannecouque, C; Song, S; Sun, L; Zhan, P1

Other Studies

1 other study(ies) available for nadolol and dolutegravir

ArticleYear
Design, synthesis and biological evaluation of 3-hydroxyquinazoline-2,4(1H,3H)-diones as dual inhibitors of HIV-1 reverse transcriptase-associated RNase H and integrase.
    Bioorganic & medicinal chemistry, 2019, 09-01, Volume: 27, Issue:17

    Topics: Anti-HIV Agents; Caco-2 Cells; Cell Line; Cell Membrane Permeability; Dose-Response Relationship, Drug; Drug Design; Enzyme Inhibitors; HIV Integrase; HIV Reverse Transcriptase; HIV-1; HIV-2; Humans; Models, Molecular; Molecular Structure; Quinazolinones; Ribonuclease H, Human Immunodeficiency Virus; Structure-Activity Relationship

2019